Cross-protection between group A and group B streptococci due to cross-reacting surface proteins

被引:31
作者
Stålhammar-Carlemalm, M [1 ]
Areschoug, T [1 ]
Larsson, C [1 ]
Lindahl, G [1 ]
机构
[1] Univ Lund, Dept Lab Med, S-22362 Lund, Sweden
关键词
D O I
10.1086/315693
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The R28 protein of group A streptococcus (GAS) and the Rib protein of group B streptococcus (GBS) are surface molecules that elicit protective immunity to experimental infection. These proteins are members of the same family and cross-react immunologically, In spite of extensive amino acid residue identity, the cross-reactivity between R28 and Rib was found to be limited, as shown by analysis with highly purified proteins and specific antisera, Nevertheless, immunization of mice with purified R28 conferred protection against lethal infection with Rib-expressing GBS strains, and immunization with Rib conferred protection against R28-expressing GAS. Thus, R28 and Rib elicited cross-protective immunity. Characterization of many clinical GAS and GBS isolates expressing R28 or Rib, respectively, indicated that most of them expressed proteins similar to those of the reference strains. Analysis of these data suggests that cross-protection may influence the outcome of natural infections with R28-expressing GAS and Rib-expressing GBS.
引用
收藏
页码:142 / 149
页数:8
相关论文
共 41 条
[1]  
AKERSTROM B, 1985, J IMMUNOL, V135, P2589
[2]  
Areschoug T, 1999, INFECT IMMUN, V67, P6350
[3]  
Baker C.J., 1995, INFECT DIS FETUS NEW, V37, P980
[4]  
BEVANGER L, 1985, ACTA PATH MICRO IM B, V93, P121
[5]   Current concepts - Streptococcal infections of skin and soft tissues [J].
Bisno, AL ;
Stevens, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :240-245
[6]   New protective antigen of group A streptococci [J].
Dale, JB ;
Chiang, EY ;
Liu, SY ;
Courtney, HS ;
Hasty, DL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1261-1268
[7]   Invasive group a streptococcal infections in Ontario, Canada [J].
Davies, HD ;
McGeer, A ;
Schwartz, B ;
Green, K ;
Cann, D ;
Simor, AE ;
Low, DE ;
Fletcher, A ;
Kaul, R ;
Scriver, S ;
Willey, B ;
Demers, B ;
Gold, W ;
Lovgren, M ;
Talbot, J ;
Naus, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08) :547-554
[8]   DEMONSTRATION OF OPSONIC ACTIVITY AND INVIVO PROTECTION AGAINST GROUP-B STREPTOCOCCI TYPE-III BY STREPTOCOCCUS-PNEUMONIAE TYPE-14 ANTISERA [J].
FISCHER, GW ;
LOWELL, GH ;
CRUMRINE, MH ;
BASS, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (03) :776-786
[9]   STREPTOCOCCAL M-PROTEIN - MOLECULAR DESIGN AND BIOLOGICAL BEHAVIOR [J].
FISCHETTI, VA .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (03) :285-314
[10]   MOLECULAR-SPECIES OF R-PROTEIN ANTIGENS PRODUCED BY CLINICAL ISOLATES OF GROUP-B STREPTOCOCCI [J].
FLORES, AE ;
FERRIERI, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (05) :1050-1054